新冠病毒肺炎中的抗凝蛋白S：活性水平降低可能是继发性的。 - Suppr

Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary.

作者信息

Baicus Cristian, Stoichitoiu Laura Elena, Pinte Larisa, Badea Camelia

机构信息

Department of Internal Medicine, Colentina University Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

出版信息

Am J Ther. 2021;28(1):e139-e140. doi: 10.1097/MJT.0000000000001306.

DOI:10.1097/MJT.0000000000001306

PMID:33369912

Abstract

摘要

相似文献

Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary.

Am J Ther. 2021;28(1):e139-e140. doi: 10.1097/MJT.0000000000001306.

Downregulation of protein S in patients with severe COVID-19 augments the prothrombotic state.

Thromb Res. 2024 Jun;238:129-131. doi: 10.1016/j.thromres.2024.04.021. Epub 2024 May 1.

Protein C and S activities in COVID-19: A systematic review and meta-analysis.

J Thromb Thrombolysis. 2024 Aug;57(6):1018-1030. doi: 10.1007/s11239-024-02971-6. Epub 2024 May 9.

Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.

Blood Coagul Fibrinolysis. 1996 Apr;7(3):325-30.

Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives.

Isr Med Assoc J. 2020 Aug;22(8):516-518.

COVID-19 coagulopathy: an evolving story.

Lancet Haematol. 2020 Jun;7(6):e425. doi: 10.1016/S2352-3026(20)30151-4.

[Acquired protein C or S deficiency--its relationship with physiopathology].

Rinsho Ketsueki. 1992 Jun;33(6):756-62.

An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor.

Am J Case Rep. 2020 Oct 30;21:e926728. doi: 10.12659/AJCR.926728.

[Expanded blood coagulation screening--a necessity in diagnosis and therapy of thrombosis?].

Vasa Suppl. 1992;35:92-3.

Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.

Blood Coagul Fibrinolysis. 1994 Aug;5(4):609-16.

引用本文的文献

Unfolded von Willebrand factor binds protein S and reduces anticoagulant activity.

Blood Vessel Thromb Hemost. 2025 Feb;2(1). doi: 10.1016/j.bvth.2024.100030. Epub 2024 Sep 25.

Dysregulation of Protein S in COVID-19.

Best Pract Res Clin Haematol. 2022 Sep;35(3):101376. doi: 10.1016/j.beha.2022.101376. Epub 2022 Aug 23.

The Mutual Relationship among Cardiovascular Diseases and COVID-19: Focus on Micronutrients Imbalance.

Nutrients. 2022 Aug 21;14(16):3439. doi: 10.3390/nu14163439.

Predictive Role of Haematological Determinants on Outcomes of Critically Ill COVID-19 Patients Admitted to Intensive Care Unit.

Cureus. 2021 Jul 30;13(7):e16764. doi: 10.7759/cureus.16764. eCollection 2021 Jul.

The Role of Vitamin K in Humans: Implication in Aging and Age-Associated Diseases.

Antioxidants (Basel). 2021 Apr 6;10(4):566. doi: 10.3390/antiox10040566.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary.

作者信息

Baicus Cristian, Stoichitoiu Laura Elena, Pinte Larisa, Badea Camelia

机构信息

Department of Internal Medicine, Colentina University Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

出版信息

Am J Ther. 2021;28(1):e139-e140. doi: 10.1097/MJT.0000000000001306.

DOI:10.1097/MJT.0000000000001306

PMID:33369912

Abstract

摘要

相似文献

Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary.

Am J Ther. 2021;28(1):e139-e140. doi: 10.1097/MJT.0000000000001306.

Downregulation of protein S in patients with severe COVID-19 augments the prothrombotic state.

Thromb Res. 2024 Jun;238:129-131. doi: 10.1016/j.thromres.2024.04.021. Epub 2024 May 1.

Protein C and S activities in COVID-19: A systematic review and meta-analysis.

J Thromb Thrombolysis. 2024 Aug;57(6):1018-1030. doi: 10.1007/s11239-024-02971-6. Epub 2024 May 9.

Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.

Blood Coagul Fibrinolysis. 1996 Apr;7(3):325-30.

Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives.

Isr Med Assoc J. 2020 Aug;22(8):516-518.

COVID-19 coagulopathy: an evolving story.

Lancet Haematol. 2020 Jun;7(6):e425. doi: 10.1016/S2352-3026(20)30151-4.

[Acquired protein C or S deficiency--its relationship with physiopathology].

Rinsho Ketsueki. 1992 Jun;33(6):756-62.

An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor.

Am J Case Rep. 2020 Oct 30;21:e926728. doi: 10.12659/AJCR.926728.

[Expanded blood coagulation screening--a necessity in diagnosis and therapy of thrombosis?].

Vasa Suppl. 1992;35:92-3.

Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.

Blood Coagul Fibrinolysis. 1994 Aug;5(4):609-16.

引用本文的文献

Unfolded von Willebrand factor binds protein S and reduces anticoagulant activity.

Blood Vessel Thromb Hemost. 2025 Feb;2(1). doi: 10.1016/j.bvth.2024.100030. Epub 2024 Sep 25.

Dysregulation of Protein S in COVID-19.

Best Pract Res Clin Haematol. 2022 Sep;35(3):101376. doi: 10.1016/j.beha.2022.101376. Epub 2022 Aug 23.

The Mutual Relationship among Cardiovascular Diseases and COVID-19: Focus on Micronutrients Imbalance.

Nutrients. 2022 Aug 21;14(16):3439. doi: 10.3390/nu14163439.

Predictive Role of Haematological Determinants on Outcomes of Critically Ill COVID-19 Patients Admitted to Intensive Care Unit.

Cureus. 2021 Jul 30;13(7):e16764. doi: 10.7759/cureus.16764. eCollection 2021 Jul.

The Role of Vitamin K in Humans: Implication in Aging and Age-Associated Diseases.

Antioxidants (Basel). 2021 Apr 6;10(4):566. doi: 10.3390/antiox10040566.

Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary.

作者信息

机构信息

出版信息

相似文献

引用本文的文献